AMPK Methods and Protocols

(Rick Simeone) #1

  1. Larach DB, deGoma EM, Rader DJ (2012)
    Targeting high density lipoproteins in the pre-
    vention of cardiovascular disease? Curr Cardiol
    Rep 14(6):684–691. https://doi.org/10.
    1007/s11886-012-0317-3

  2. Rader DJ, Tall AR (2012) The not-so-simple
    HDL story: is it time to revise the HDL cho-
    lesterol hypothesis? Nat Med 18
    (9):1344–1346. https://doi.org/10.1038/
    nm.2937. nm.2937 [pii]
    14.GalicS,FullertonMD,SchertzerJD,SikkemaS,
    Marcinko K, Walkley CR, Izon D, Honeyman J,
    Chen ZP, van Denderen BJ, Kemp BE, Steinberg
    GR (2011) Hematopoietic AMPK beta1 reduces
    mouse adipose tissue macrophage inflammation
    and insulin resistance in obesity. J Clin Invest 121
    (12):4903–4915. https://doi.org/10.1172/
    JCI58577

  3. Fullerton MD, Steinberg GR, Schertzer JD
    (2013) Immunometabolism of AMPK in insu-
    lin resistance and atherosclerosis. Mol Cell
    Endocrinol 366(2):224–234. https://doi.
    org/10.1016/j.mce.2012.02.004

  4. O’Neill LA, Hardie DG (2013) Metabolism of
    inflammation limited by AMPK and pseudo-
    starvation. Nature 493(7432):346–355.
    https://doi.org/10.1038/nature11862

  5. Day EA, Ford RJ, Steinberg GR (2017) AMPK
    as a therapeutic target for treating metabolic
    diseases. Trends Endocrinol Metab.https://
    doi.org/10.1016/j.tem.2017.05.004

  6. Li D, Wang D, Wang Y, Ling W, Feng X, Xia M
    (2010) Adenosine monophosphate activated
    protein kinase induces cholesterol efflux from
    macrophage-derived foam cells and alleviates
    atherosclerosis in apolipoprotein E-deficient
    mice. J Biol Chem 285(43):33499–33509.
    https://doi.org/10.1074/jbc.M110.159772.
    M110.159772 [pii]

  7. Cao Q, Cui X, Wu R, Zha L, Wang X, Parks JS,
    Yu L, Shi H, Xue B (2016) Myeloid deletion of
    alpha1AMPK exacerbates atherosclerosis in
    low density lipoprotein receptor knockout
    (LDLRKO) mice. Diabetes.https://doi.org/
    10.2337/db15-0917

  8. Zhang M, Zhu H, Ding Y, Liu Z, Cai Z, Zou
    MH (2017) AMP-activated protein kinase
    alpha1 promotes atherogenesis by increasing
    monocyte-to-macrophage differentiation. J
    Biol Chem. https://doi.org/10.1074/jbc.
    M117.779447

  9. Pinkosky SL, Newton RS, Day EA, Ford RJ,
    Lhotak S, Austin RC, Birch CM, Smith BK,
    Filippov S, Groot PH, Steinberg GR, Lalwani
    ND (2016) Liver-specific ATP-citrate lyase
    inhibition by bempedoic acid decreases
    LDL-C and attenuates atherosclerosis. Nat
    Commun 7:13457. https://doi.org/10.
    1038/ncomms13457
    22. Wang J, Ma A, Zhao M, Zhu H (2017) AMPK
    activation reduces the number of atheromata
    macrophages in ApoE deficient mice. Athero-
    sclerosis 258:97–107. https://doi.org/10.
    1016/j.atherosclerosis.2017.01.036
    23. Fullerton MD, Ford RJ, McGregor CP,
    LeBlond ND, Snider SA, Stypa SA, Day EA,
    Lhotak S, Schertzer JD, Austin RC, Kemp BE,
    Steinberg GR (2015) Salicylate improves mac-
    rophage cholesterol homeostasis via activation
    of Ampk. J Lipid Res 56(5):1025–1033.
    https://doi.org/10.1194/jlr.M058875
    24. Kim J, Kwak HJ, Cha JY, Jeong YS, Rhee SD,
    Kim KR, Cheon HG (2014) Metformin sup-
    presses lipopolysaccharide (LPS)-induced
    inflammatory response in murine macrophages
    via activating transcription factor-3 (ATF-3)
    induction. J Biol Chem 289
    (33):23246–23255. https://doi.org/10.
    1074/jbc.M114.577908
    25. Jeong HW, Hsu KC, Lee JW, Ham M, Huh JY,
    Shin HJ, Kim WS, Kim JB (2009) Berberine
    suppresses proinflammatory responses through
    AMPK activation in macrophages. Am J Phys
    Endocrinol Metab 296(4):E955–E964.https://
    doi.org/10.1152/ajpendo.90599.2008
    26. Buttari B, Profumo E, Segoni L,
    D’Arcangelo D, Rossi S, Facchiano F, Saso L,
    Businaro R, Iuliano L, Rigano R (2014) Res-
    veratrol counteracts inflammation in human
    M1 and M2 macrophages upon challenge
    with 7-oxo-cholesterol: potential therapeutic
    implications in atherosclerosis. Oxidative Med
    Cell Longev 2014:257543.https://doi.org/
    10.1155/2014/257543
    27. Tsai JS, Chuang LM, Chen CS, Liang CJ,
    Chen YL, Chen CY (2014) Troglitazone and
    Delta2Troglitazone enhance adiponectin
    expression in monocytes/macrophages
    through the AMP-activated protein kinase
    pathway. Mediat Inflamm 2014:726068.
    https://doi.org/10.1155/2014/726068
    28. Namgaladze D, Snodgrass RG, Angioni C,
    Grossmann N, Dehne N, Geisslinger G,
    Brune B (2015) AMP-activated protein kinase
    suppresses arachidonate 15-lipoxygenase
    expression in interleukin 4-polarized human
    macrophages. J Biol Chem 290
    (40):24484–24494. https://doi.org/10.
    1074/jbc.M115.678243
    29. Lin XL, Liu MH, HJ H, Feng HR, Fan XJ, Zou
    WW, Pan YQ, Hu XM, Wang Z (2015) Curcu-
    min enhanced cholesterol efflux by upregulat-
    ing ABCA1 expression through AMPK-
    SIRT1-LXRalpha signaling in THP-1 macro-
    phage-derived foam cells. DNA Cell Biol 34
    (9):561–572. https://doi.org/10.1089/dna.
    2015.2866


Assessing Macrophage Cholesterol Homeostasis 493
Free download pdf